Concepedia

Otto Soepenberg

OS

8

Publications

279

Citations

8

H-Index

1994

Active since

Affiliations

Erasmus MC(Current)

National Cancer Institute

Otto Soepenberg is an author at Erasmus MC specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

1994–2017

8

Publications

8

Phase I Pharmacokinetic, Food Effect, and Pharmacogenetic Study of Oral Irinotecan Given as Semisolid Matrix Capsules in Patients with Solid Tumors

Otto Soepenberg, Herlinde Dumez, Jaap Verweij et al. · Clinical Cancer Research · 2005 · 85 citations · Full text

Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors

Otto Soepenberg, Maja J.A. de Jonge, Alex Sparreboom et al. · Clinical Cancer Research · 2005 · 73 citations · Full text

Real-time pharmacokinetics guiding clinical decisions

Otto Soepenberg, Alex Sparreboom, Maja J.A. de Jonge et al. · European Journal of Cancer · 2004 · 36 citations

, , +3

Phase I and Pharmacokinetic Study of Oral Irinotecan Given Once Daily for 5 Days Every 3 Weeks in Combination With Capecitabine in Patients With Solid Tumors

Otto Soepenberg, Herlinde Dumez, Jaap Verweij et al. · Journal of Clinical Oncology · 2005 · 28 citations · Full text

A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours

L. C. Scott, Otto Soepenberg, Jaap Verweij et al. · Annals of Oncology · 2007 · 22 citations · Full text

, , +8

Rows per page

1–5 of 8